• Endogenous H2S Deficiency in Diabetic Cardiomyopathy

  2026-09-05

  Guo and colleagues identify reduced endogenous hydrogen sulfide production as a mechanistic contributor to lipotoxic injury in diabetic cardiomyopathy, linking H2S deficiency with endoplasmic reticulum stress, lipid accumulation, and cardiomyocyte apoptosis. Their complementary patient, animal, and cell models show that H2S supplementation and ER-stress inhibition produce protective effects, while also highlighting the value of spatially resolved methods for future validation.

• Septin4, VHL, and HIF-1α in Hypoxic Cardiomyocytes

  2026-09-04

  The reference study identifies Septin4 as a previously underappreciated aggravator of hypoxia-induced cardiomyocyte injury. Its experiments connect Septin4 to HIF-1α through a VHL-dependent ubiquitination and proteasomal degradation pathway, providing a mechanistic explanation for increased apoptosis under low-oxygen stress.

• Caspofungin and the Next Era of Glucan Targeting

  2026-09-04

  Caspofungin is more than a familiar antifungal control: it is a mechanistically defined probe for glucan biology, resistance-aware assay design, and delayed-treatment modeling. This thought-leadership analysis connects the compound’s β-(1,3)-D-glucan mechanism with translational strategy for azole-resistant Candida, including Candida auris.

• Stiripentol: LDH Inhibitor Research Guide

  2026-09-03

  Stiripentol is a chemically distinct LDH inhibitor used as an epilepsy research compound and investigated for lactate-pathway modulation. Product information describes noncompetitive inhibition of human LDH1 and LDH5, while recent tumor-immunometabolism research links lactate accumulation with histone lactylation and immune dysfunction.

• EZ Cap™ Cy5 EGFP mRNA: LNP Assay Guide

  2026-09-03

  Separate mRNA uptake from productive translation with a single dual-fluorescence reporter. This workflow shows how to use Cy5-labeled mRNA to benchmark targeted lipid nanoparticles, optimize delivery conditions, and troubleshoot discordant imaging and EGFP results.

• Dual-Action Inhibitors and p38α Dephosphorylation

  2026-09-02

  A 2024 bioRxiv preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they also accelerate removal of the activation-loop phosphate by WIP1. Biochemical experiments and X-ray structures link this effect to an inhibitor-stabilized activation-loop conformation, suggesting a route to more durable and selective control of kinase signaling.

• Budesonide for Pulmonary Permeability Workflows

  2026-09-02

  Build a more informative respiratory research workflow by pairing Budesonide-driven inflammation assays with biomimetic membrane-partitioning screens. This approach uses IAM LC for broad, automatable profiling and LEKC when phospholipid interactions and pulmonary permeability are the primary questions.

• I-BET151 in BET and Disulfidptosis Assays

  2026-09-01

  I-BET151 (GSK1210151A) provides a reversible way to test how BET-dependent transcription influences prostate cancer phenotypes, including SLC7A11-associated disulfidptosis. This workflow combines chromatin profiling, glucose-stress experiments, apoptosis assay controls, and cell cycle arrest assay readouts to distinguish mechanism from nonspecific cytotoxicity.

• SR-202: PPARγ Antagonist Workflow Guide

  2026-09-01

  SR-202 enables controlled interrogation of PPARγ-dependent adipogenesis, macrophage polarization, and immunometabolic signaling. This practical guide connects antagonist-based experiments with insulin resistance research, obesity research, and inflammatory disease models while separating validated findings from proposed workflow parameters.

• Taihangia rupestris: Wild vs Cultivated Leaves

  2026-08-31

  This RSC Advances study combines UPLC-MS/MS, complementary antioxidant assays, α-glucosidase inhibition testing, active-compound screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest measured antioxidant and enzyme-inhibitory activities, supporting cultivation as a potentially conservation-compatible source of antidiabetic lead compounds.

• EPI-001: Mapping AR N-Terminal Signaling

  2026-08-31

  EPI-001 is an androgen receptor N-terminal domain inhibitor suited to dissecting ligand-independent AR biology. This guide translates prostate cancer and TNBC findings into a domain-aware experimental strategy for measuring transcriptional, molecular, and phenotypic responses.

• Sumatriptan: From 5-HT1 Biology to Translation

  2026-08-30

  A translational perspective on Sumatriptan Succinate, linking 5-HT1B/1D pharmacology and CGRP biology with assay design, pediatric emergency workflows, inflammation research, and strategic development decisions.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-29

  Oh et al. establish a scalable human induced pluripotent stem cell-derived sensory neuron system that reproduces major molecular and chromatin features of latent HSV-1 infection. The model also supports experimentally induced reactivation, providing a human-relevant platform for studying neuron-intrinsic latency mechanisms and antiviral strategies.

• Estrogen Receptor–Autophagy Axis in Perimenopause

  2026-08-28

  This study integrates NHANES population data, network pharmacology, and perimenopausal mouse experiments to connect declining estradiol with cardiometabolic and renal vulnerability. Its central advance is experimental evidence that receptor-dependent autophagy contributes to estrogen-mediated protection of the heart, aorta, and kidneys, while also clarifying the limits of translating these findings directly to hormone therapy.

• Tamoxifen: A Decision Framework for Better Assays

  2026-08-28

  Tamoxifen is more than a selective estrogen receptor modulator: it is a context-dependent perturbation tool spanning estrogen signaling, CreER-mediated gene knockout, cancer models, and pathogen assays. This guide provides an evidence-aware framework for choosing controls, interpreting phenotypes, and avoiding cross-domain overclaims.

8500 records 1/567 page Next 12345 下5页 Last page